Publication date: Sep 14, 2024
(1) Background: early in the COVID-19 pandemic, reverse transcription polymerase chain reaction (RT-PCR) testing was limited. Assessing seroprevalence helps understand prevalence and reinfection risk. However, such data are lacking for the first epidemic wave in Belgian nursing homes. Therefore, we assessed SARS-CoV-2 seroprevalence and cumulative RT-PCR positivity in Belgian nursing homes and evaluated reinfection risk. (2) Methods: we performed a cross-sectional study in nine nursing homes in April and May 2020. Odds ratios (ORs) were calculated to compare the odds of (re)infection between seropositive and seronegative participants. (3) Results: seroprevalence was 21% (95% CI: 18-23): 22% (95% CI: 18-25) in residents and 20% (95% CI: 17-24) in staff. By 20 May 2020, cumulative RT-PCR positivity was 16% (95% CI: 13-21) in residents and 8% (95% CI: 6-12) in staff. ORs for (re)infection in seropositive (compared to seronegative) residents and staff were 0. 22 (95% CI: 0. 06-0. 72) and 3. 15 (95% CI: 1. 56-6. 63), respectively. (4) Conclusion: during the first wave, RT-PCR test programmes underestimated the number of COVID-19 cases. The reinfection rate in residents was 3%, indicating protection, while it was 21% in staff, potentially due to less cautious health behaviour. Future outbreaks should use both RT-PCR and serological testing for complementary insights into transmission dynamics.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
drug | DRUGBANK | Etoperidone |
disease | MESH | COVID-19 pandemic |
disease | MESH | reinfection |
disease | MESH | infection |
drug | DRUGBANK | Coenzyme M |
disease | MESH | Infectious Diseases |
drug | DRUGBANK | Gold |
disease | IDO | symptom |
disease | MESH | influenza |
disease | MESH | dementia |
disease | IDO | blood |
drug | DRUGBANK | Oxygen |
disease | MESH | morbidities |